Attitude of the Adult Patient With Atopic Dermatitis to the Disease and Its Treatment: The ACTIDA Study

Betlloch, I.; Izu, R.; Lleonart, M.; Ferrer, M.; Ferrando, J.

doi:10.1016/S1578-2190(10)70600-4

Actas Dermo-Sifiliográficas

ISSN: 0001-7310

The Official publication of the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermo-Sifiliográficas, founded in 1909, is the oldest monthly medical journals published in Spain. In the year 2006 has been indexed in the Medlinedatabase, and has become a vehicle for expressing the most current Spanish medicine and modern. All articles are subjected to a rigorous process of revision in pairs, and careful editing for literary and scientific style. Together with the classic Original and Clinical Case Study sections, we also include Reviews, Case Diagnoses, and Book Reviews. Dermo-Sifiliográficas is an essential publication for anyone who needs to be current on all aspects of Spanish and world dermatology.

Actas Dermo-Sifiliográficas ha recibido Factor de Impacto (JCR) por primera vez en 2023.
Guía para autores - Envío de manuscritos

Actas Dermo-Sifiliográficas has received its first journal Impact Factor (JCR) in 2023.
Instructions for authors - Submit an article

Indexed in:

Web of Science, Emerging Sources Citation Index (WoS, Clarivate), PubMed/Medlinee, IME, Embase/Excerpta Medica, Embase, Toxline, Cab Abstracts, Cab Health, Cancerlit NIm, Serline: Biomed, Bibliomed, Pascal, Scopus , IBECS

Two hundred twenty-seven dermatologists recruited 1441 analyzable patients, the majority women, with a mean of 3.6 outbreaks per year. Most of the patients (97.2%) indicated that they always or sometimes requested medical evaluation of a new outbreak. In the most recent outbreak, 72.2% had used combined therapy, regardless of the severity of the episode; 2-drug combinations were the most common. The majority of dermatologists prescribed combined therapy, most commonly a 2-drug combination for mild or minimal disease, and 3 or more drugs for moderate to very severe outbreaks.

Conclusions

Treatments used by patients for an outbreak of AD are similar to those prescribed by dermatologists in recent outbreaks.

Keywords:

Atopic dermatitis

Treatment

Patient attitude

Resumen

Introducción y objetivos

Conocer la actitud de los pacientes adultos frente a la dermatitis atópica (DA) y su tratamiento.

Material y métodos

Estudio transversal, multicéntrico, realizado en pacientes con al menos 2 brotes en el último año.

Resultados

Doscientos veintisiete dermatólogos reclutaron 1.441 pacientes analizables, mayoritariamente mujeres con 3,6 brotes al año de media. La mayoría de los pacientes (97,2%) indicó que solicitaba, al menos ocasionalmente, asesoramiento médico ante nuevos brotes. El 72,2% recurrió a la terapia combinada (TC) en el último brote, independientemente de su intensidad, siendo las combinaciones de 2 fármacos (TC2) las más utilizadas. Los dermatólogos indicaron mayoritariamente TC, siendo la TC2 más frecuente para formas leves y casi sin enfermedad, y la TC de más de 2 fármacos en brotes moderados a muy graves.

Conclusiones

Los tratamientos empleados por los pacientes ante un brote de DA son similares a los indicados por los dermatólogos.

Palabras clave:

Dermatitis atópica

Tratamiento

Actitud del paciente

Full text is only aviable in PDF

References

[1.]

A.Y. Finlay.

Quality of life in atopic dermatitis.

J Am Acad Dermatol, 45 (2002), pp. S64-S66

Medline

[2.]

G. Kiebert, S.V. Sorensen, D. Revicki, S.C. Fagan, J.J. Doyle, J. Cohen, et al.

Atopic dermatitis is associated with a decrement in health-related quality of life.

Int J Dermatol, 41 (2002), pp. 151-158

Medline

[3.]

M.L. Levy.

Atopic dermatitis: understanding the disease and its management.

Curr Med Res Opin, 23 (2007), pp. 3091-3103

http://dx.doi.org/10.1185/030079907X242593 | Medline

[4.]

I.I. Williams, C. Robertson, A. Stewart, N. Aït-Khaled, G. Anabwani, R. Anderson, et al.

Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood.

J Allergy Clin Immunol, 103 (1999), pp. 125-138

Medline

[5.]

H. Williams.

Epidemiology of atopic dermatitis: recent advances and future predictions.

Curr Probl Dermatol, 28 (1999), pp. 9-17

Medline

[6.]

H. Williams.

Epidemiology of atopic dermatitis.

Clin Exp Dermatol, 25 (2000), pp. 522-529

Medline

[7.]

B. Wuthrich.

Clinical aspects, epidemiology and prognosis of atopic dermatitis.

Ann Allergy Asthma Immunol, 83 (1999), pp. 464-470

http://dx.doi.org/10.1016/S1081-1206(10)62852-9 | Medline

[8.]

C.E. Correale, C. Walter, L.N. Murphy, T.J. Graig.

Atopic dermatitis: A review of diagnosis and treatment.

Am Fam Phys, 60 (1999), pp. 1191-1198

[9.]

J. Méndez-Cabeza, H. Alache, E. Cerrada.

Manejo de la dermatitis atópica en Atención Primaria.

Medifam, 13 (2003), pp. 75-84

[10.]

E. Baselga.

Tratamiento de la dermatitis atópica en la infancia.

Actas Dermosifiliogr, 94 (2003), pp. 345-355

[11.]

R.O. McAlister, S.J. Tofte, J.J. Doyle, A. Jackson, J.M. Hanifin.

Patient and physician perspectives vary on atopic dermatitis.

Cutis, 69 (2002), pp. 461-466

Medline

[12.]

C.R. Charman, A.J. Venn, H. Williams, M. Bigby.

Measuring atopic eczema severity visually.

Arch Dermatol, 141 (2005), pp. 1146-1151

http://dx.doi.org/10.1001/archderm.141.9.1146 | Medline

[13.]

E.D. Baron, D. Barzilai, G. Johnston, M. Kawashima, M. Takigawa, H. Nakagawa, et al.

Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, USA and UK.

Br J Dermatol, 147 (2002), pp. 710-715

Medline

[14.]

L.F. Eichenfield, A.W. Lucky, M. Boguniewicz, R.G.B. Langley, R. Cherill, K. Marshall, et al.

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

J Am Acad Dermatol, 46 (2002), pp. 495-504

Medline

[15.]

C. Ellis, T. Luger, D. Abeck, R. Allen, R.A.C. Graham-Brown, Y. De Prost, L.F. Einchenfield, C. Ferrándiz, on behalf of the ICCAD Faculty, et al.

International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies.

Br J Dermatol, 148 (2003), pp. 3-10

Medline

[16.]

D. Rudikoff.

Atopic dermatitis-Treatment Update.

US Dermatol Rev, (2006), pp. 1-5

[17.]

N. Barbier, C. Paul, T. Luger, R. Allen, Y. De Prost, K. Papp, et al.

Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1,550 patients from the pimecrolimus cream 1% randomized controlled trials programme.

Br J Dermatol, 150 (2004), pp. 90-102

Medline

Indexed in:

Follow us:

Subscribe to our newsletter